An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye

Background: The role of sclerotherapy for acute variceal bleeding is challenged by vasoactive drugs and by ligation.
Aim: A meta-analysis was performed to evaluate whether sclerotherapy remains a gold standard in acute variceal bleeding.
Methods: Sclerotherapy was evaluated across four randomized trial groups: (a) combined with vasoconstrictors vs. vasoconstrictors alone (five trials, with 400 patients); (b) vs. vasoconstrictors alone (15 trials, with 1296 patients); (c) vs. combination of vasoconstrictors and sclerotherapy (eight trials, with 1026 patients); (d) vs. ligation (12 trials, with 1309 patients). We used the risk difference (absolute risk reduction) as our main effect measure.
Results: The efficacy of acute sclerotherapy was highest vs. ligation at 95 %, with a small advantage for ligation (an overtube was used in eight trials) of 2.5 % (95 % CI 0.4 % to 4.6 %) (P = 0.018), but no survival difference. Efficacy of sclerotherapy combined with vasoconstrictors vs. vasoconstrictors alone was 86 %, whereas it was 83 % for sclerotherapy vs. vasoconstrictors alone. In both these groups sclerotherapy was superior for control of bleeding at, respectively, 16.3 % (95 % CI 8.7 % to 23.9 % (P = 0.0001) and 5.9 % (95 % CI, 1.5 % to 10.3 %) (P = 0.008), with increased survival in the latter. In the combination group of sclerotherapy with vasoconstrictors, the efficacy of sclerotherapy alone was 69 %, with the combination superior in controlling bleeding, at 13.2 % (95 % CI, 8.4 % to 18.1 %) (P < 0.0001) but with no survival difference.
Conclusion: This comparison of sclerotherapy across trials demonstrates a problem in defining its real efficacy. The conclusive evidence for substituting banding ligation or the combination of vasoconstrictors with sclerotherapy as better therapeutic approaches has not been provided in randomized trials. Sclerotherapy can remain a gold standard in variceal bleeding but there is scope for further studies of ligation and vasoactive drugs.

References

• 1 The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices . Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.  N Engl J Med. 1988;  319 983-989
• 2 McCormick P A, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades.  Gut. 2001;  49 682-685
• 3 Soares-Weiser K, Brezis M, Tur-Kaspa R. et al . Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding [review].  Cochrane Database Syst Rev. 2002;  2 CD002907
• 4 Hou M C, Lin H C, Liu T T. et al . Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.  Hepatology. 2004;  39 746-753
• 5 Goulis J, Patch D, Burroughs A K. Bacterial infection in the pathogenesis of variceal bleeding.  Lancet. 1999;  353 139-142
• 6 Crafoord C, Frenckner P. New surgical treatment of varicose veins of the oesophagus.  Acta Otolaryngol. 1939;  27 422-429
• 7 De Franchis R, Banares R, Silvain C. Emergency endoscopy strategies for improved outcomes.  Scand J Gastroenterol (Suppl). 1998;  226 25-36
• 8 Hartigan P M, Gebhard R L, Gregory P B. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group.  Gastrointest Endosc. 1997;  46 1-7
• 9 Stiegmann G V, Goff J S, Michaletz-Onody P A. et al . Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.  N Engl J Med. 1992;  326 1527-1532
• 10 D’Amico G, Pietrosi G, Tarantino I. et al . Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.  Gastroenterology. 2003;  124 1277-1291
• 11 Triantos C, Samonakis D, Patch D. et al . Sclerotherapy versus vasoactive drugs. Are all meta-analyses the same?.  Gastroenterology. 2004;  127 358-359
• 12 Alexandrino P, Alves P, Fidalgo M. et al . Is sclerotherapy the first choice treatment for active oesophageal variceal bleeding in cirrhotic patients? Final report of a randomized controlled trial [abstract].  J Hepatol. 1990;  11 S1
• 13 Larson A W, Cohen H, Zweiban B. et al . Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial.  JAMA. 1986;  255 497-500
• 14 Novella M, Villanueva C, Ortiz J. et al . Octreotide vs. sclerotherapy and octreotide for acute variceal bleeding. A pilot study [abstract].  Hepatology. 1996;  24 207A
• 15 Soderlund C, Ihre T. Endoscopic sclerotherapy v. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment.  Acta Chir Scand. 1985;  151 449-456
• 16 Villanueva C, Ortiz J, Sabat M. et al . Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial.  Hepatology. 1999;  30 384-389
• 17 Bildozola M, Kravetz D, Argonz J. et al . Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial.  Scand J Gastroenterol. 2000;  35 419-425
• 18 Escorsell A, Del Arbol L R, Planas R. et al . Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.  Hepatology. 2000;  32 471-476
• 19 Freitas D S, Sofia C, Pontes J M. et al . Octreotide in acute bleeding esophageal varices: a prospective randomized study.  Hepatogastroenterology. 2000;  47 1310-1314
• 20 Jenkins S A, Shields R, Davies M. et al . A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage.  Gut. 1997;  41 526-533
• 21 Planas R, Quer J C, Boix J. et al . A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding.  Hepatology. 1994;  20 370-375
• 22 Ramires R P, Zils C K, Mattos A A. Sclerotherapy versus somatostatin in the treatment of upper digestive hemorrhage caused by rupture of esophageal varices.  Arq Gastroenterol. 2000;  37 148-154
• 23 Shields R, Jenkins S A, Baxter J N. et al . A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices.  J Hepatol. 1992;  16 128-137
• 24 Sivri B, Oksuzoglu G, Bayraktar Y. et al . A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.  Hepatogastroenterology. 2000;  47 168-173
• 25 Sung J J, Chung S C, Lai C W. et al . Octreotide infusion or emergency sclerotherapy for variceal haemorrhage.  Lancet. 1993;  342 637-641
• 26 Westaby D, Hayes P C, Gimson A E. et al . Controlled clinical trial of injection sclerotherapy for active variceal bleeding.  Hepatology. 1989;  9 274-277
• 27 Yousuf M, Rauf A, Baig I. et al . Initial management of acute variceal haemorrhage. Comparison of octreotide and sclerotherapy.  J Coll Phys Surg Pak. 2000;  10 95-97
• 28 Di Fedo G, Siringo S, Vacirca M. et al . Somatostatin (SMS) and urgent sclerotherapy (US) in active oesophageal variceal bleeding [abstract].  Gastroenterology. 1990;  98 583A
• 29 El-Jackie A, Rowaisha I, Waked I. et al . Octreotide vs. sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: a randomized trial [abstract].  Hepatology. 1998;  28 553
• 30 Lopez F, Vargas R, Margarita G. et al . Octreotide vs sclerotherapy in the treatment of acute variceal bleeding [abstract].  Hepatology. 1999;  30 574A
• 31 Poo J, Bosques S, Guarduno R. et al . Octreotide versus emergency sclerotherapy in acute variceal hemorrhage in liver cirrhosis. A randomized multicenter study [abstract].  Gastroenterology. 1996;  110 A1297
• 32 Avgerinos A, Nevens F, Raptis S. et al . Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial.  Lancet. 1997;  350 1495-1499
• 33 Besson I, Ingrand P, Person B. et al . Sclerotherapy with or without octreotide for acute variceal bleeding.  N Engl J Med. 1995;  333 555-560
• 34 Cales P, Masliah C, Bernard B. et al . Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension.  N Engl J Med. 2001;  344 23-28
• 35 Farooqi J, Farooqi R, Haq N. et al . Treatment and outcome of variceal bleeding - A comparison of two methods.  JCPSP. 2000;  10 131-133
• 36 Zuberi B F, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.  Am J Gastroenterol. 2000;  95 768-771
• 37 Signorelli S, Negrini F, Paris B. et al . Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: our experience.  Gastroenterology. 1996;  110 1326A
• 38 Signorelli S, Paris B, Negrini F. et al . Octreotide and endoscopic variceal sclerotherapy in the management of acute variceal haemorrhage [abstract].  Endoscopy. 1999;  31 E66
• 39 Fakhry S, Omar M, Mustafa A. et al . Endoscopic sclerotherapy versus endoscopic variceal ligation in the management of bleeding esophageal varices: a final report of a prospective randomized study in schistosomal hepatic fibrosis [abstract].  Hepatology. 1997;  26 137A
• 40 Gimson A E, Ramage J K, Panos M Z. et al . Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.  Lancet. 1993;  342 391-394
• 41 Hou M C, Lin H C, Kuo B I. et al . Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial.  Hepatology. 1995;  21 1517-1522
• 42 Jain A K, Ray R P, Gupta J. Management of acute variceal bleed: randomized trial of variceal ligation and sclerotherapy [abstract].  Hepatology. 1996;  23 I-51
• 43 Jensen D, Kovacs T, Jutabha R. et al . Randomized, blinded prospective study of banding vs. sclerotherapy for preventing recurrent variceal hemorrhage for patients without active bleeding at endoscopy [abstract].  Gastrointest Endosc. 1993;  41 315A
• 44 Laine L, el Newihi H M, Migikovsky B. et al . Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices.  Ann Intern Med. 1993;  119 1-7
• 45 Lo G H, Lai K H, Cheng J S. et al . A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices.  Hepatology. 1995;  22 466-471
• 46 Lo G H, Lai K H, Cheng J S. et al . Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices.  Hepatology. 1997;  25 1101-1104
• 47 Salem S, Shiha G. A prospective randomized trial of sclerotherapy versus saeed six-shooter multiband ligation in the control of acute bleeding from oesophageal varices [abstract].  Gut. 1999;  44 (Suppl 1) A19
• 48 Sarin S K, Govil A, Jain A K. et al . Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
• 49 Shafqat F, Khan A A, Alam A. et al . Band ligation vs endoscopic sclerotherapy in esophageal varices: a prospective randomized comparison.  J Pak Med Assoc. 1998;  48 192-196
• 50 Papatheodoridis G V, Goulis J, Leandro G. et al . Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis.  Hepatology. 1999;  30 612-622
• 51 Laupacis A, Sackett D L, Roberts R S. An assessment of clinically useful measures of the consequences of treatment.  N Engl J Med. 1988;  318 1728-1733
• 52 Leandro G. Meta-analysis in medical research. Oxford; Blackwell Publishing Ltd 2004
• 53 The Copenhagen Esophageal Varices Sclerotherapy Project . Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial.  N Engl J Med. 1984;  311 1594-1600
• 54 El Zayadi A, ElDin S S, Kabil S M. Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease.  Gastrointest Endosc. 1988;  34 314-317
• 55 Escorsell A, Bordas J M, del Arbol L R. et al . Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.  J Hepatol. 1998;  29 779-788
• 56 Primignani M, Andreoni B, Carpinelli L. et al . Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club.  Hepatology. 1995;  21 1322-1327
• 57 Burroughs A K. International Octreotide Varices Study Group. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures [abstract].  Hepatology. 1996;  24 325A
• 58 Moreto M, Zaballa M, Ruiz-Rebollo L. et al . Somatostatin as an adjuvant to emergency sclerotherapy of bleeding esophageal varices [abstract].  Gut. 1994;  35 A178
• 59 Abd-Elrazec W, Omar N, Khalil M. et al . Urgent endoscopy vs. octreotide in the management of acute variceal bleeding in patients with advanced encephalopathy [abstract].  J Hepatol. 2005;  42 (Suppl) 87
• 60 Avgerinos A, Armonis A, Manolakopoulos S. et al . Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.  J Hepatol. 1997;  26 1034-1041
• 61 Baroncini D, Milandri G L, Borioni D. et al . A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
• 62 Jensen D M, Kovacs T, Jutabha R. et al . Randomized, blinded prospective study of banding vs. sclerotherapy for preventing recurrent variceal hemorrhage for patients without active bleeding at endoscopy [abstract].  Gastrointest Endosc. 1995;  41 315A
• 63 Masci E, Norberto L, D’Imperio N. et al . Prospective multicentric randomized trial comparing banding ligation with sclerotherapy of esophageal varices.  Gastrointest Endosc.. 1997;  45 847A
• 64 Mundo F, Mitrani C, Rodriguez G, Farca A. Endoscopic variceal treatment, is band ligation taking over sclerotherapy? [abstract].  Am J Gastroenterol. 1993;  88 1493A
• 65 Serwah A A, Habba M R, AbdelHamid A S. Endoscopic variceal ligation compared with endoscopic sclerotherapy for bleeding oesophageal varices: a randomised controlled trial [abstract].  J Hepatol. 2004;  40 (Suppl 1) 73
• 66 Villanueva C, Minana J, Ortiz J. et al . Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.  N Engl J Med. 2001;  345 647-655
• 67 De Franchis R. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices.  Dig Liver Dis. 2004;  36 (Suppl 1) S93-S100
• 68 Banares R, Albillos A, Rincon D. et al . Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis.  Hepatology. 2002;  35 609-615
• 69 Makuch R W, Pledger G, Hall D B. et al .Active control equivalence studies. In: Peace K, editor Statistical issues in drug research and development. New York; Marcel Dekker 1990: 225-262
• 70 Jones B, Jarvis P, Lewis J A. et al . Trials to assess equivalence: the importance of rigorous methods.  BMJ. 1996;  313 36-39
• 71 Altman D G. Octreotide infusion versus injection sclerotherapy.  Lancet. 1993;  342 1486
• 72 Grace N D, Groszmann R J, Garcia-Tsao G. et al . Portal hypertension and variceal bleeding: an AASLD single topic symposium.  Hepatology. 1998;  28 868-880
• 73 Chan L Y, Sung J J. Review article: the role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasis.  Aliment Pharmacol Ther. 1997;  11 45-50
• 74 Burroughs A K, Patch D. Therapeutic benefit of vaso-active drugs for acute variceal bleeding: a real pharmacological effect, or a side-effect of definitions in trials?.  Hepatology. 1996;  24 737-739
• 75 De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.  J Hepatol. 2000;  33 846-852
• 76 Burroughs A K, McCormick P A, Hughes M D. et al . Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding.  Gastroenterology. 1990;  99 1388-1395
• 77 Burroughs A K. Assessment of value of consensus definitions in acute variceal bleeding.  Lancet. 2001;  357 1147-1148
• 78 Shimm D S, Spece R G Jr. Industry reimbursement for entering patients into clinical trials: legal and ethical issues.  Ann Intern Med. 1991;  115 148-151
• 79 Sung J J, Chung S C, Yung M Y. et al . Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation.  Lancet. 1995;  346 1666-1669
• 80 Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices?.  Hepatology. 1995;  22 663-665
• 81 Sauerbruch T, Schepke M. Sclerotherapy is out - nearly.  Endoscopy. 1997;  29 281-282